RGEN
USDRepligen Corporation Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$149.060
Haut
$151.250
Bas
$146.000
Volume
0.61M
Fondamentaux de l'Entreprise
Capitalisation Boursière
8.3B
Industrie
Medical Instruments & Supplies
Pays
United States
Statistiques de Trading
Volume Moyen
0.92M
Bourse
NMS
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
Repligen Corporation to Present at Upcoming November Conferences
WALTHAM, Mass., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be attending five upcoming
Canaccord Genuity Maintains Hold on Repligen, Raises Price Target to $165
Canaccord Genuity analyst Kyle Mikson maintains Repligen with a Hold and raises the price target from $150 to $165.
Barclays Maintains Overweight on Repligen, Raises Price Target to $175
Barclays analyst Luke Sergott maintains Repligen with a Overweight and raises the price target from $160 to $175.
Repligen Reports Third Quarter 2025 Financial Results and Updates Full Year 2025 Financial Guidance
Revenue of $189 million, year-over-year increase of 22% as reported and 18% organic with double-digit reported growth across all franchisesOrders increased sequentially and greater than 20% year-over-yearIncreasing
Repligen to Report Third Quarter 2025 Financial Results
WALTHAM, Mass., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN) today announced that the Company will report its third quarter 2025 financial results on Tuesday, October 28, 2025. The Company will
Actions Connexes
PRS
Prudential Financial Inc. 5.625% Junior Subordinated Notes due 2058
OESX
Orion Energy Systems Inc.
SGH
SMART Global Holdings Inc. Ordinary Shares
THRM
Gentherm Inc
ETON
Eton Pharmaceuticals Inc.
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.